MedPath

Implementation of Nationwide Skin Cancer Screening Platform using Artificial Intelligence technology

Phase 1
Recruiting
Conditions
Skin cancer patients, including melanoma, basal cell carcinoma and squamous cell carcinoma
artificial intelligence, machine learning, melanoma, pigmented skin lesions, skin cancer screening
Registration Number
TCTR20211101004
Lead Sponsor
Thailand Science Research and Innovation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
624
Inclusion Criteria

Male or female patents
Age more than 18 years old
Who has skin lesion(s) that is suspected for skin cancer and visits the Sub-district Health Promoting Hospitals of 1st-12th Area Health in Thailand.

Exclusion Criteria

The patient who was once diagnosed skin cancer.
The suspected skin lesion(s) is located in the area that is difficult to be shot by the camera, such as ear canals, nasal canals, intraorbital area, vagina or rectum.
The patient doesn't give an informed consent for photo shooting.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
numbers and percentage of system-assisted referred patients 12 months after the beginning of the study number and percentage of patients
Secondary Outcome Measures
NameTimeMethod
Patient's self awareness about skin cancer 12 months after the beginning of the study ratio of number of patients that have self awareness / patients that neglect about the existing skin cancer lesions
© Copyright 2025. All Rights Reserved by MedPath